The team traced the change to a network of genes that flips during development. By probing that genetic switch in human tissue models, they found a way to nudge neurons back toward a youthful, growth-friendly state. An existing hormone drug produced a clear increase in nerve fiber regrowth in these organoids, suggesting a biochemical route to restore damaged circuits.
This work matters because it maps molecular levers that could broaden recovery after spinal cord or brain injuries and because it uses human-derived tissue models rather than solely animal systems. The idea that lost regenerative capacity can be reawakened raises questions about safety, timing, and how therapies might support learning and function as regrown fibers reconnect. Follow the full report to explore how these findings might reshape approaches to rehabilitation, neurotechnology, and inclusive treatments for people with chronic nerve damage.
Cambridge researchers created miniature brain-and-spinal-cord systems in the lab that can send signals and even trigger tiny muscle contractions. They discovered that human neurons gradually lose their ability to regrow after damage during development — but that ability can potentially be switched back on. The team identified a gene network controlling this process and found that an existing hormone drug dramatically boosted nerve fiber regrowth.
